Ticker

Vancouver, British Columbia--(Newsfile Corp. - April 23, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into a strategic product marketing agreement with Raw Creation, a UK-headquartered creative agency ("Raw Creation"), to provide certain social media management, creative content, editorial, paid advertising and related marketing…

Vancouver, British Columbia--(Newsfile Corp. - April 16, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a company focused on the next-generation of peptide-based products and delivery systems, commends the U.S. Food and Drug Administration (FDA) for its recent actions to advance regulatory clarity surrounding peptide substances. The FDA's decision to remove several peptides…

Vancouver, British Columbia--(Newsfile Corp. - April 15, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") is pleased to announce that it has entered into agreements with i) Think Ink Marketing Data and Email Services ("Think Ink") and ii) Ouimet Consulting Inc. ("Ouimet") to provide certain investor relations services to the Company. Think Ink The Company has entered into a…

Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a

Vancouver, BC – March 13, 2026 – TheNewswire - Pangea Wellness Inc. (“Pangea” or the “Company”) (CSE: PNGA) (OTC: PNGAF) announces that further to the Company's news release dated March 6, 2026, the effective date of the name change from “Pangea Wellness Inc.” to The Precision Peptide Company Inc.” will be March 18, 2026.   The Company's common shares will begin trading on the CSE on March 18, 2026 under the new…